20050306
 Panel Suggests Limit On Gene Therapy   The Wall Street Journal,  Mar 7, 2005  "What is happening here today -- the big picture -- is that it shows the difficulty in developing any new class of therapy," said Dr. Daniel Salomon, professor in the Scripps Research Institute and a member of the FDA panel. "There was a period of time that there was a tendency to say gene therapy . . . had been safe. What's clear now is that [problems can develop in] some gene therapy for some diseases."   
